Anidulafungin
Anidulafungin
CLINICAL USE
Antifungal agent:
Invasive candidiasis
DOSE IN NORMAL RENAL FUNCTION
200 mg loading dose then 100 mg daily
Oesophageal candidiasis: 100 mg loading
dose then 50 mg daily
PHARMACOKINETICS
Molecular weight                           :
1140.2
%Protein binding                           :
>99
%Excreted unchanged in urine     :
<1
Volume of distribution (L/kg)       :
30–50 litres
half-life – normal/ESRD (hrs)      :
40–50/Unchanged
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           :
Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :
Not dialysed. Dose as in normal renal function
HD                     :
Not dialysed. Dose as in normal renal function
HDF/high flux   :
Unlikely to be dialysed. Dose as in
normal renal function
CAV/VVHD      :
Unlikely to be dialysed. Dose as in
normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
None known
ADMINISTRATION
Reconstition
With diluent provided
Route
IV infusion
Rate of Administration
1.1 mg/minute (3 mL/minute)
Comments
Can be further diluted in sodium chloride
0.9% or glucose 5%.
Add 100 mg to 250 mL or 200 mg to
500 mL of fluid
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home